INTRODUCTION
============

Hidradenitis suppurativa (HS) is a chronic, relapsing skin condition characterized by deep-seated nodules, boils, and abscesses that sometimes lead to sinus tract and fistula formation \[[@b1-aps-2019-00290]\]. Although the etiology of HS is unclear, it is known to be a disorder of the sebaceous glands and terminal hair follicles of apocrine gland-bearing skin \[[@b2-aps-2019-00290]\]. Due to the associated malodorous discharge, long-term pain, and scarring, the psychosocial functioning of patients with HS is often impaired. HS has a significant impact on patients' quality of life, professional activity, and self-esteem \[[@b3-aps-2019-00290]\].

Several epidemiological studies of HS have been performed in Western nations, with the estimated prevalence of HS ranging from 0.05% to 4.0% \[[@b1-aps-2019-00290]\]. HS predominantly affects obese women, and it typically occurs in the axillae, breasts, and anogenital areas of Caucasian and African individuals. It is less common in Hispanics and Asian people \[[@b4-aps-2019-00290]\].

Contrary to these demographic data from Western nations, most Japanese patients with HS are men whose lesions are on the buttocks; relatively few of these patients present with lesions in apocrine-bearing areas, such as the axilla \[[@b5-aps-2019-00290]\].

Wet earwax is a normal secretory product of the ceruminous apocrine glands, whereas dry earwax forms due to a genetically reduced number of apocrine glands \[[@b6-aps-2019-00290],[@b7-aps-2019-00290]\]. A single-nucleotide polymorphism, 538G\>A in the *ABCC11* gene, determines the type of earwax that an individual produce \[[@b7-aps-2019-00290]\]. G/A heterozygotes and G/G homozygotes produce wet earwax, whereas A/A homozygotes produce dry earwax. Wet earwax has complete autosomal dominance over the dry type. Wet earwax is found in almost 100% of European and African populations, as well as in most (50%--70%) Southeast Asian, Oceanian, Central Asian, and Native American individuals. In contrast, dry earwax is highly specific to East Asian populations, with a frequency of 80%--95% \[[@b7-aps-2019-00290],[@b8-aps-2019-00290]\]. Only 12% of Japanese individuals produce wet earwax \[[@b6-aps-2019-00290]\].

We therefore hypothesized that the clinical characteristics of Japanese patients with HS are different from those of patients in the West, and we placed a special emphasis on the type of earwax most often seen associated with this disease. We evaluated earwax type in a cohort of Japanese HS patients. In addition, we compared the clinical characteristics of patients with wet versus dry earwax.

METHODS
=======

This study, which was conducted with the approval of the Institutional Review Board (IRB No. 2487) of Showa University, conforms to the standards established in the Declaration of Helsinki. Written consent for use of their photographs was obtained from all patients. Between May 2010 and June 2018, we retrospectively reviewed the medical charts of Japanese patients who met the criteria for an HS diagnosis according to standard guidelines ([Table 1](#t1-aps-2019-00290){ref-type="table"}). Although most of the patients had been diagnosed with pyoderma chronica or acne conglobata, all also met the diagnostic criteria for HS. The patients' demographic information and clinical characteristics―sex, age of onset, family history of HS, affected area(s), and earwax type―were investigated.

We particularly focused our statistical analyses on differences in the clinical characteristics of those with wet versus dry earwax. Variables were compared using the chi-square test. A value of P\<0.05 was considered to indicate statistical significance. All statistical analyses were performed using Microsoft Excel 2013 (Microsoft Corp., Redmond, WA, USA).

RESULTS
=======

In total, we reviewed the medical charts of 53 patients. [Table 2](#t2-aps-2019-00290){ref-type="table"} shows their demographic data and clinical characteristics. Of the 53 patients, 38 were male (71.7%) and 15 were female (28.3%). The mean age at onset of HS was 32.4 years, and the mean duration of the disease was 7.6 years. Patients with obesity (characterized by a body mass index ≥30 kg/m^2^) comprised 13.2% of the 53 patients. Overall, 84.9% were current or former smokers. A family history of HS was found in 30.2% of the second-degree relatives of the patients. Some patients had HS that affected two or more areas of the body. The gluteal area was most often affected ([Fig. 1](#f1-aps-2019-00290){ref-type="fig"}), followed by the anogenital/inguinal and periauricular areas. Only nine patients had lesions in the axillae ([Fig. 2](#f2-aps-2019-00290){ref-type="fig"}). Other uncommon areas of HS occurrence included the chin, nape of the neck, shoulder, back, and thigh. Wet earwax was observed in 27 of the 53 patients, whereas dry earwax was observed in 26. There were no significant differences in these variables between the sexes.

When the clinical characteristics of patients with wet and dry earwax were compared, no significant differences were found regarding sex, age at onset of HS, disease duration, smoking status, or body mass index. As shown in [Table 3](#t3-aps-2019-00290){ref-type="table"}, however, 14 of the 27 patients with wet earwax had a positive family history of HS, whereas only two of the 26 patients with dry earwax had such a history (P\<0.001).

We divided the patients into two groups: a "gluteal" group, consisting of patients who had lesions on their buttocks only (n=15), and an "other-areas" group, consisting of all other patients (n=38). Among the 27 patients with wet earwax, two had HS only on their buttocks. In contrast, among the 26 patients with dry earwax, 13 were categorized into the gluteal group, while 13 had HS on other areas (P\<0.01). Thus, the gluteal group predominantly included those with dry earwax (13 of 15 patients), whereas the other-areas group predominantly included those with wet earwax (25 of 37 patients).

DISCUSSION
==========

HS has traditionally been viewed as a chronic, relapsing inflammatory disorder of the sweat glands. Although most HS-affected areas are apocrine gland--rich, these glands are not the primary target of the pathological process of the disease \[[@b9-aps-2019-00290]\]. The involvement of apocrine glands in HS is still under debate, as not only apocrine-rich areas but also intertriginous areas (e.g., the inframammary fold) are commonly affected. The pathogenesis of HS is currently thought to be multifactorial and likely heterogeneous \[[@b9-aps-2019-00290]\]. Previously reported risk factors include being of African or Caucasian origin, being female, smoking, and obesity \[[@b2-aps-2019-00290]\]. An autosomal dominant inheritance pattern is observed in one-third of HS patients \[[@b1-aps-2019-00290]\].

The wet variety of earwax has complete autosomal dominance over the dry type. In this regard, Japan is unique in that only 12% of individuals have wet earwax \[[@b6-aps-2019-00290]\]. Hence, it is noteworthy that half of the Japanese patients with HS in the present study were found to have wet earwax. Excluding the gluteal group, 25 of 37 patients had wet earwax (resulting from the G allele of the *ABCC11* gene), which may be another risk factor for HS in this group. It could be interesting to investigate the earwax type resulting from the *ABCC11* genotype in Asian and Hispanic patients with HS.

Atypical histopathological findings are common in HS. These include intrafollicular hyperkeratosis, which causes plugging and rupture of the hair follicles, followed by perifollicular lymphocytic infiltration, abscess formation, sinus tracts with stratified squamous epithelium, and fibrosis \[[@b2-aps-2019-00290],[@b10-aps-2019-00290]\]. In this study, we found no histological differences between the lesions of patients with wet earwax and those with dry earwax because all patients had completely disrupted, non-functioning sweat glands.

Anatomically, the distribution of apocrine glands is limited to the ear canals, axillae, breasts, and perianal area. Apocrine glands are not found in the skin of the buttocks. In a few studies conducted in the West, the clinical features of patients with gluteal HS were found to be different from those of other subgroups \[[@b11-aps-2019-00290]\]. Canoui-Poitrine et al. \[[@b11-aps-2019-00290]\] divided HS into three subgroups―axillary-mammary, follicular, and gluteal―and reported that gluteal HS was predominant in males and was associated with smoking, but not with obesity \[[@b1-aps-2019-00290],[@b11-aps-2019-00290]\]. Similarly, in the present study, patients characterized by lesions only in the apocrine gland--poor buttock area were predominantly men and smokers to a statistically significant degree. Only one patient had a family history of HS. In addition, the proportion of patients with wet earwax (2 of 16 patients) was approximately equivalent to that in the general Japanese population.

In Korea, ≤5% of individuals are known to have wet earwax \[[@b7-aps-2019-00290],[@b8-aps-2019-00290]\]. Interestingly, similarly to Japanese HS patients, Korean HS patients are predominantly male, and the most commonly affected area in these patients is also the buttocks \[[@b12-aps-2019-00290]\]. The recently reported prevalence of HS in Korea was low (0.06%) \[[@b13-aps-2019-00290]\]. Although the prevalence of HS in Japan has not been investigated, Kurokawa et al. \[[@b5-aps-2019-00290]\] surmised that it was lower than that in Western nations.

In Western nations, the sites most commonly affected by HS are the inguinal and axillary areas, with the gluteal area being only the third most common site \[[@b1-aps-2019-00290]\]. We suggest that both Japanese and Korean patients with HS are most commonly affected on their buttocks. Thus, patients in Japan and Korea are less likely to be affected in their apocrine gland-bearing skin areas, such as the axillae, than are either Africans or Caucasians. As shown in [Table 2](#t2-aps-2019-00290){ref-type="table"}, when patients who exhibited HS only on their buttocks were excluded, the frequency of a family history of HS was significantly higher, and the proportion of patients with wet earwax (25 of 37 patients) was extremely high. As previously noted, the pathogenesis of HS is multifactorial \[[@b9-aps-2019-00290]\]. Gluteal HS may be more closely associated with environmental factors (e.g., cigarette smoking), whereas lesions in apocrine gland-bearing skin may be associated more strongly with genetic factors. In fact, some physicians and surgeons prefer to diagnose gluteal symptoms as pyoderma chronica glutealis rather than gluteal HS \[[@b5-aps-2019-00290]\].

Previous studies have led to the proposition of several HS subtypes \[[@b11-aps-2019-00290],[@b14-aps-2019-00290]\]. As clinical characteristics and pathogenesis differ by subtype, the optimal treatment of the subtypes may also be different \[[@b14-aps-2019-00290]\]. Canoui-Poitrine et al. \[[@b11-aps-2019-00290]\] reported that cases of gluteal HS were less severe than those of other subtypes. General advice to stage I HS patients includes lifestyle modification, weight control, and smoking cessation. For such mild lesions, Lee et al. \[[@b13-aps-2019-00290]\] recommended topical or oral administration of antibiotics prior to incision and drainage of the lesion. Administration of some hormones, such as antiandrogens and corticosteroids, has also been recommended \[[@b2-aps-2019-00290]\]. For moderate to severe lesions, radical excision of affected areas and the surrounding tissues is the most common treatment \[[@b2-aps-2019-00290],[@b10-aps-2019-00290]\]. The defects are primarily closed, then treated using negative-pressure wound healing therapy. Alternatively, they are reconstructed with skin grafting or local flaps. Deroofing of sinus lesions and carbon dioxide laser treatments are also used \[[@b10-aps-2019-00290]\]. Recently, a human monoclonal antibody to tumor necrosis factor alpha proved to be an efficacious treatment for moderate to severe HS in Western patients \[[@b2-aps-2019-00290]\]. For the reasons that we have indicated, physicians examining patients suspected of having HS and investigators in charge of clinical trials should take the type of earwax of the patient into account.

As we hypothesized, the present study indicated that wet earwax was associated with HS. However, this study consisted of subjects who were referred for plastic surgery to a limited number of treatment centers in central Tokyo. Based on our results, a nationwide, multicenter survey is warranted to clarify the clinical features of Japanese patients with HS. We believe that East Asian nations, including Japan and Korea, could provide suitable populations for studies to determine the association of wet earwax and/or the *ABCC11* gene with HS.
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![Typical cases of hidradenitis suppurativa\
Both patients were current smokers. (A) A 51-year-old man presented with Hurley stage III hidradenitis suppurativa (HS) on the buttocks only. The patient had dry earwax and no family history of HS. (B) A 54-year-old man presented with Hurley stage III HS in the perianal area that extended into the gluteal area, as well as stage II HS in the periauricular area. The patient had wet earwax and had two daughters with HS.](aps-2019-00290f1){#f1-aps-2019-00290}

![Other cases photographs of hidradenitis suppurativa\
(A) A 32-year-old man presented with Hurley stage II hidradenitis suppurativa on the periauricular region. (B) A 25-year-old man presented with Hurley stage II hidradenitis suppurativa on the bilateral axillae. Both patients were current smokers and had wet earwax.](aps-2019-00290f2){#f2-aps-2019-00290}

###### 

Diagnostic criteria for hidradenitis suppurativa \[[@b2-aps-2019-00290]\]

  ---------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Primary positive diagnostic criteria     
                                           History: painful or suppurating lesions that recurred more than twice in 6 months
                                           Signs: involvement of the axilla, genitofemoral area, perineum, gluteal area, or (in women) the inframammary area; presence of nodules (inflamed or non-inflamed), sinus tracts (inflamed or non-inflamed), abscesses, or scarring (atrophic, mesh-like, red, hypertrophic, or linear)
  Secondary positive diagnostic criteria   
                                           History: family history of hidradenitis suppurativa
                                           Microbiology: a negative swab or the presence of normal skin microbiota may be indicative of hidradenitis suppurativa
  ---------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Patients' characteristics (n=53)

  Characteristic                                                    No. (%)
  ----------------------------------------------------------------- -----------
  Sex                                                               
   Male                                                             38 (71.7)
   Female                                                           15 (28.3)
  Mean age at disease onset (yr)                                    32.4
  Mean disease duration (yr)                                        7.6
  Body mass index (kg/m^2^)                                         
   \< 30                                                            46 (86.8)
   ≥ 30                                                             7 (13.2)
  Smoking status                                                    
   Current or former smoker                                         45 (84.9)
   Nonsmoker                                                        8 (15.1)
  Positive family history of hidradenitis suppurativa               16 (30.2)
  Affected areas^[a)](#tfn1-aps-2019-00290){ref-type="table-fn"}^   
   Gluteal                                                          22 (41.5)
   Anogenital/inguinal                                              16 (30.2)
   Periauricular                                                    15 (28.3)
   Axillary                                                         9 (17.0)
   Mammary                                                          2 (3.8)
   Other^[b)](#tfn2-aps-2019-00290){ref-type="table-fn"}^           5 (9.4)
  Type of earwax                                                    
   Wet                                                              27 (50.9)
   Dry                                                              26 (49.1)

Some patients suffered from hidradenitis suppurativa in two or more bodily areas;

Other areas include the chin, nape of the neck, shoulder, back, and thigh.

###### 

Patients' characteristics according to the presence of wet or dry earwax

  Characteristic                                                  Wet earwax (n = 27)   Dry earwax (n = 26)   P-value^[a)](#tfn3-aps-2019-00290){ref-type="table-fn"}^
  --------------------------------------------------------------- --------------------- --------------------- ----------------------------------------------------------
  Family history of hidradenitis suppurativa                                                                  \< 0.001
   Yes                                                            14                    2                     
   No/unknown                                                     13                    24                    
  Affected area                                                                                               \< 0.01
   Buttocks only                                                  2                     13                    
   Other sites^[b)](#tfn4-aps-2019-00290){ref-type="table-fn"}^   25                    13                    

Values are presented as number.

These values were obtained using the chi-square test;

Details of the other sites are described in the Methods section. Six of these patients experienced hidradenitis suppurativa on their buttocks as well.
